Disease activity in and quality of life of patients with psoriatic arthritis mutilans: the Nordic PAM Study

References

• Ibrahim G, Waxman R, Helliwell PS. The prevalence of psoriatic arthritis in people with psoriasis. Arthritis Rheum 2009;61:1373–8.
   PubMed Web of Science ®Google Scholar
• Love TJ, Gudbjornsson B, Gudjonsson JE, Valdimarsson H. Psoriatic arthritis in Reykjavik, Iceland: prevalence, demographics, and disease course. J Rheumatol 2007;34:2082–8.
   PubMed Web of Science ®Google Scholar
• Nossent JC, Gran JT. Epidemiological and clinical characteristics of psoriatic arthritis in northern Norway. Scand J Rheumatol 2009;38:251–5.
   PubMed Web of Science ®Google Scholar
• Pedersen OBV, Svendsen AJ, Ejstrup L, Skytthe A, Junker P. The occurrence of psoriatic arthritis in Denmark. Ann Rheum Dis 2008;67:1422–6.
   PubMed Web of Science ®Google Scholar
• Haglund E, Bremander AB, Petersson IF, Strömbeck B, Bergman S, Jacobsson LT, et al. Prevalence of spondyloarthritis and its subtypes in southern Sweden. Ann Rheum Dis 2011;70:943–8.
   PubMed Web of Science ®Google Scholar
• Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H, et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006;54:2665–73.
   PubMed Web of Science ®Google Scholar
• Haroon M, Kirby B, Fitzgerald O. High prevalence of psoriatic arthritis in patients with severe psoriasis with suboptimal performance of screening questionnaires. Ann Rheum Dis 2013;72:736–40.
   PubMed Web of Science ®Google Scholar
• Walsh JA, Callis DK, Krueger GG, Clegg DO. Limitations in screening instruments for psoriatic arthritis: a comparison of instruments in patients with psoriasis. J Rheumatol 2013;40:287–93.
   PubMed Web of Science ®Google Scholar
• Mease PJ, Gladman DD, Papp KA, Khraishi MM, Thaçi D, Behrens F, et al. Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics. J Am Acad Dermatol 2013;69:729–35.
   PubMed Web of Science ®Google Scholar
• Zachariae H, Zachariae R, Blomqvist K, Davidsson S, Molin L, Mörk C, et al. Quality of life and prevalence of arthritis reported by 5,795 members of the Nordic Psoriasis Associations: data from the Nordic quality of life study. Acta Derm Venereol 2002;82:108–13.
   PubMed Web of Science ®Google Scholar
• Moll JM, Wright V. Psoriatic arthritis. Semin Arthritis Rheum 1973;3:55–78.
   PubMedGoogle Scholar
• Eder L, Gladman DD. Psoriatic arthritis: phenotypic variance and nosology. Curr Rheumatol Rep 2013;15:316–23.
   PubMed Web of Science ®Google Scholar
• Gladman DD, Farewell VT, Nadeau C. Clinical indicators of progression in psoriatic arthritis: multivariate relative risk model. J Rheumatol 1995;22:675–9.
   PubMed Web of Science ®Google Scholar
• Gudbjornsson B, Ejstrup L, Gran JT, Iversen L, Lindqvist U, Paimela L, et al. Psoriatic arthritis mutilans (PAM) in the Nordic countries: demographics and disease status. The Nordic PAM study. Scand J Rheumatol 2013;42:373–8.
   PubMed Web of Science ®Google Scholar
• Gladman DD, Antoni C, Mease P, Clegg DO, Nash P. Psoriatic arthritis: epidemiology, clinical features, course and outcome. Ann Rheum Dis 2005;64:ii14–17.
   PubMed Web of Science ®Google Scholar
• Theander E, Husmark T, Alenius G-M, Larsson PT, Teleman A, Geijer M, et al. Early psoriatic arthritis: short symptom duration, male gender and preserved physical functioning at presentation predict favourable outcome at 5-year follow-up. Results from the Swedish Early Psoriatic Arthritis Register (SwePsA). Ann Rheum Dis 2014;73:407–13.
   PubMed Web of Science ®Google Scholar
• Yoshida M, Belt EA, Kaarela K, Kauppi MJ, Shimamura T. Prevalence of mutilans-like hand deformities in patients with seropositive rheumatoid arthritis. A prospective 20-year study. Scand J Rheumatol 1999;28:38–40.
   PubMed Web of Science ®Google Scholar
• Haddad A, Chandran V. Arthritis mutilans. Curr Rheumatol Rep 2013;15:321–5.
   PubMed Web of Science ®Google Scholar
• Lindqvist U, Rudsander A, Boström A, Nilsson B, Michaëlsson G. IgA antibodies to gliadin and coeliac disease in psoriatic arthritis. Rheumatology (Oxford) 2002;41:31–7.
   PubMed Web of Science ®Google Scholar
• Fries JF, Spitz PW, Young DY. The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales. J Rheumatol 1982;9:789–93.
   PubMed Web of Science ®Google Scholar
• Daltroy LH, Larson MG, Roberts NW, Liang MH. A modification of the Health Assessment Questionnaire for the spondyloarthropathies. J Rheumatol 1990;17:946–50.
   PubMed Web of Science ®Google Scholar
• Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473–83.
   PubMed Web of Science ®Google Scholar
• Sullivan M, Karlsson J, Ware J Jr. The Swedish SF-36 Health Survey--I. Evaluation of data quality, scaling assumptions, reliability and construct validity across general populations in Sweden. Soc Sci Med 1995;41:1349–58.
   PubMed Web of Science ®Google Scholar
• Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI): a simple practical measure for routine clinical use. Clin Exp Dermatol 1994;19:210–16.
   PubMed Web of Science ®Google Scholar
• Lewis V, Finlay AY. 10 years experience of the Dermatology Life Quality Index (DLQI). J Investig Dermatol Symp Proc 2004;9:169–80.
   PubMed Web of Science ®Google Scholar
• Lee S, Mendelsohn A, Sarnes E. The burden of psoriatic arthritis: a literature review from a global health systems perspective. P T 2010;35:680–9.
   PubMedGoogle Scholar
• Feldtkeller E, Khan MA, Van Der Heijde D, Van Der Linden S, Braun J. Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol Int 2003;23:61–6.
   PubMed Web of Science ®Google Scholar
• Chandran V, Gladman DD, Helliwell PS, Gudbjörnsson B. Arthritis mutilans: a report from the GRAPPA 2012 Annual Meeting. J Rheumatol 2013;40:1419–22.
   PubMed Web of Science ®Google Scholar
• Chandran V, Thavaneswaran A, Pellett PJ, Gladman DD. The association between human leukocyte antigen and killer-cell immunoglobulin-like receptor gene variants and the development of arthritis mutilans in patients with psoriatic arthritis (abstract). Arthritis Rheum 2011;63( Suppl):S307.
   Google Scholar
• Queiro R, Tejón P, Alonso S, Coto P. Age at disease onset: a key factor for understanding psoriatic disease. Rheumatology (Oxford) 2014;53:1178–85.
   PubMed Web of Science ®Google Scholar
• Swanbeck G, Inerot A, Martinsson T, Wahlström J, Enerbäck C, Enlund F. Age at onset and different types of psoriasis. Br J Dermatol 1995;133:768–73.
   PubMed Web of Science ®Google Scholar
• Mallbris L, Larsson P, Bergqvist S, Vingård E, Granath F, Ståhle M. Psoriasis phenotype at disease onset: clinical characterization of 400 adult cases. J Invest Dermatol 2005;124:499–504.
   PubMed Web of Science ®Google Scholar
• The Nordic countries in figures 2008 (www.norden.org/sv/fakta-om-norden/siffror-och-statistik). Accessed 2 January 2017.
   Google Scholar
• Lindqvist UR, Alenius GM, Husmark T, Theander E, Holmström G, Larsson PT. The Swedish early psoriatic arthritis register – 2-year follow-up: a comparison with early rheumatoid arthritis. J Rheumatol 2008;35:668–73.
   PubMed Web of Science ®Google Scholar
• Husted JA, Tom BD, Farewell VT, Schentag CT, Gladman DD. A longitudinal study of the effect of disease activity and clinical damage on physical function over the course of psoriatic arthritis: does the effect change over time? Arthritis Rheum 2007;56:840–9.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Moreno J, Bonet M, Del Blanco Barnusell J, Castano C, Clavaquera T, Mateo Soria L, et al. Mutilating/resorptive arthritis. A study of 24 patients in a series of 360 patients with psoriatic arthritis. Rheumatol Clin 2013;9:38–41.
   Google Scholar